首页 | 官方网站   微博 | 高级检索  
     

康莱特治疗肺癌研究进展
引用本文:李峻岭,储大同.康莱特治疗肺癌研究进展[J].中国肿瘤临床,2012,39(16):1139-1142.
作者姓名:李峻岭  储大同
作者单位:中国医学科学院北京协和医学院肿瘤医院(北京市100021)
摘    要:康莱特注射液的成分为注射用薏苡仁油, 中医的功能主治为益气养阴, 消肿散结。在临床上单用或与化疗联合, 主要用于晚期非小细胞肺癌的治疗。研究显示康莱特注射液与常规疗法联合治疗非小细胞肺癌, 可提高临床疗效, 减轻不良反应, 稳定并改善患者的生活质量。 

关 键 词:康莱特注射液KLT    非小细胞肺癌    研究进展
收稿时间:2012-06-25

A Review of Kanglaite Treatment for Non-small Cell Lung Cancer
Junlmg LI,Datong CHU.A Review of Kanglaite Treatment for Non-small Cell Lung Cancer[J].Chinese Journal of Clinical Oncology,2012,39(16):1139-1142.
Authors:Junlmg LI  Datong CHU
Affiliation:Beijing Cancer Hospital of the Chinese Academy of Medical Sciences and the Peking Union Medical Hospital, Beijing 100021, China
Abstract:Kanglaite (KLT) injection, composed of coix seed oil, functions by supplementing qi and nourishing yin, which reduces swelling and eliminates stagnation in traditional Chinese medicine. KLT injection has been used mainly in the clinical treatment of advanced-stage non-small cell lung cancer, whether alone or in combination with chemotherapy. Studies confirmed that KLT injection combined with chemotherapy or targeted therapy for non-small cell lung cancer patients can enhance the clinical efficacy, reduce side effects, and improve the patients' quality of life. 
Keywords:
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国肿瘤临床》浏览原始摘要信息
点击此处可从《中国肿瘤临床》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号